SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

BlackRock Health Sciences Trust BME NYSE

NYSE • Financial Services • Asset Management • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

BlackRock Health Sciences Trust (BME) is a Asset Management company in the Financial Services sector, currently trading at $40.05. It has a SharesGrow Score of 84/100, indicating a strong investment profile with 4 out of 7 criteria passed.

Financials: revenue is $36M, +34.1%/yr average growth. Net income is $77M, growing at +140.3%/yr. Net profit margin is 212.9% (strong). Gross margin is 84.4% (-57.1 pp trend).

Balance sheet: total debt is $894,332 against $568M equity (Debt-to-Equity (D/E) ratio 0, conservative). Debt-to-assets is 0.2%. Total assets: $570M.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 100/100 (Pass), Past 75/100 (Partial), Health 100/100 (Pass), Moat 41/100 (Fail), Future ?/100 (Fail), Income 100/100 (Pass).

BME SharesGrow Score Overview

86/100

SharesGrow Score

Strong investment profile

View full scorecard →

VALUE 100/100

Valuation — P/E, PEG, Forward PEG

GROWTH 100/100

Financials — average growth

PAST 75/100

strong — trend

HEALTH 100/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 41/100

Gross margin is + market cap

FUTURE 0/100

Analyst outlook — as buy

INCOME 100/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — BME

BME trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

BME: +34.1%/yr revenue is, +140.3%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

BME: 3 / 4 years profitable. mixed. Score = 3 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet BME: Debt-to-Equity (D/E) ratio 0 (conservative), Current ratio is N/A. Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

BME: Gross margin is 84.4% (-57.1 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 41/100. ≥ 70 = Pass.

View details →

No analyst coverage available for this stock.

BME: Net profit margin is 212.9%. strong (≥30%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range34.18-42.74

Volume51.61K

Avg Volume (30D)42.44K

Market Cap$517.61M

Beta (1Y)0.63

Dividend Yield$3.1452

Share Statistics

EPS (TTM)5.92

Shares Outstanding$13M

IPO Date2005-03-29

CEOCharles Choon Sik Park

Financial Highlights & Ratios

Revenue (TTM)$36.16M

Gross Profit$30.53M

EBITDA$77.01M

Net Income$76.97M

Operating Income$77M

Total Cash$4.92M

Total Debt$894.33K

Net Debt$893.78K

Total Assets$570.14M

Price / Earnings (P/E)6.8

Price / Sales (P/S)14.31

Analyst Forecast

Company Info

CountryUS

ExchangeNYSE

CurrencyUSD

ISINUS09250W1071

Price Chart

BME

BlackRock Health Sciences Trust ↗ · NYSE

Financial Services • Asset Management

34.18 52WK RANGE 42.74

People Also View

Eaton Vance Tax-Managed Global Diversified Equity Income Fund

Cohen & Steers Infrastructure Fund, Inc

Cohen & Steers Quality Income Realty Fund, Inc.

Blackrock Innovation & Growth Trust

Eaton Vance Tax-Managed Buy-Write Opportunities Fund

BlackRock Science and Technology Trust II

BlackRock Capital Allocation Trust

BlackRock Health Sciences Trust II

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message